Characterization of Pitx2c expression in the mouse heart using a reporter transgene

2010 ◽  
Vol 240 (1) ◽  
pp. 195-203 ◽  
Author(s):  
Milena B. Furtado ◽  
Christine Biben ◽  
Hidetaka Shiratori ◽  
Hiroshi Hamada ◽  
Richard P. Harvey
2008 ◽  
Vol 22 (S1) ◽  
Author(s):  
Zheng Maggie Huang ◽  
Fiona Britton ◽  
Can Yuan ◽  
Changlong An ◽  
William Hatton ◽  
...  
Keyword(s):  

2019 ◽  
Vol 11 (2) ◽  
pp. 215
Author(s):  
S. Badawi ◽  
B. Pillot ◽  
L. Augeul ◽  
M. Ovize ◽  
M. Kurdi ◽  
...  

1995 ◽  
Vol 752 (1 Cardiac Growt) ◽  
pp. 406-416 ◽  
Author(s):  
KISHORE B. S. PASUMARTHI ◽  
YAN JIN ◽  
MARGARET E. BOCK ◽  
ARISTIDES LYTRAS ◽  
ELISSAVET KARDAMI ◽  
...  

2004 ◽  
Vol 101 (39) ◽  
pp. 14234-14239 ◽  
Author(s):  
C. Forster ◽  
S. Kietz ◽  
K. Hultenby ◽  
M. Warner ◽  
J.-A. Gustafsson
Keyword(s):  

Author(s):  
Jin-Sook Kwon ◽  
Sarah M Schumacher ◽  
Erhe Gao ◽  
J Kurt Chuprun ◽  
Jessica Ibetti ◽  
...  

Recent data supporting any benefit of stem cell therapy for ischemic heart disease has suggested paracrine-based mechanisms via extracellular vesicles (EVs) including exosomes. We have previously engineered cardiac-derived progenitor cell (CDC) to express a peptide inhibitor, βARKct, of G protein-coupled receptor kinase 2, leading to improvements in cell proliferation, survival and metabolism. In this study we tested whether βARKct-CDC EVs would be efficacious when applied to stressed myocytes in vitro and in vivo. When isolated EVs from βARKct-CDC and control GFP-CDC were added to cardiomyocytes in culture, they both protected against hypoxia-induced apoptosis. We tested whether these EVs could protect the mouse heart in vivo following exposure either to myocardial infarction (MI) or acute catecholamine toxicity. Both types of EVs significantly protected against ischemic injury and improved cardiac function after MI compared to mice treated with EVs from mouse embryonic fibroblasts, however βARKct EVs treated mice did display some unique beneficial properties including significantly altered pro- and anti-inflammatory cytokines. Importantly, in a catecholamine toxicity model of heart failure (HF), myocardial injections of βARKct-containing EVs were superior at preventing HF compared to control EVs and this catecholamine toxicity protection was recapitulated in vitro. Therefore, introduction of the βARKct into cellular EVs can have improved reparative properties in the heart especially against catecholamine damage, which is significant since sympathetic nervous system activity is increased in HF.


2018 ◽  
Vol 120 ◽  
pp. 44
Author(s):  
S. Badawi ◽  
M. Ovize ◽  
L. Augeul ◽  
B. Pillot ◽  
M. Kurdi ◽  
...  
Keyword(s):  

2007 ◽  
Vol 54 (3,4) ◽  
pp. 276-288 ◽  
Author(s):  
Yuka Takehara-Kasamatsu ◽  
Kunihiro Tsuchida ◽  
Masashi Nakatani ◽  
Tatsuya Murakami ◽  
Akira Kurisaki ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document